Matrix Trust CO Abb Vie Inc. Transaction History

Matrix Trust CO

$535 Million
Q3 2024

A detailed history of Matrix Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Matrix Trust CO holds 13,419 shares of ABBV stock, worth $2.42 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

13,419

Previous 13,317 0.77%

Holding current value

$2.42 Million

Previous $2.28 Million 16.02%

% of portfolio

0.5%

Previous 0.52%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$163.84 - $199.33 $16,711 - $20,331	102 Added 0.77%	13,419 $2.65 Million
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $13,776 - $16,087	89 Added 0.67%	13,317 $2.28 Million
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $2,237 - $2,549	14 Added 0.11%	13,228 $2.41 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $12,108 - $13,637	-88 Reduced 0.66%	13,214 $2.05 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $18,836 - $21,805	141 Added 1.07%	13,302 $1.98 Million
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $64,134 - $79,811	484 Added 3.82%	13,161 $1.77 Million
Q1 2023 Apr 12, 2023	BUY	$144.61 - $166.54 $121,472 - $139,893	840 Added 7.1%	12,677 $2.02 Million
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $508,289 - $609,572	3,675 Added 45.03%	11,837 $1.91 Million
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $335,390 - $384,671	2,499 Added 44.13%	8,162 $1.1 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $419,052 - $532,753	3,045 Added 116.31%	5,663 $867,000
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $345,523 - $428,697	2,618 New	2,618 $424,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Trust CO with notifications on news.

Account